Brand Name | Status | Last Update |
---|---|---|
nalmefene hydrochloride | ANDA | 2024-12-16 |
opvee | New Drug Application | 2024-11-11 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
opioid-related disorders | EFO_0005611 | D009293 | F11 |
respiration disorders | — | D012120 | J00-J99 |
drug overdose | — | D062787 | — |
Expiration | Code | ||
---|---|---|---|
NALMEFENE HYDROCHLORIDE, OPVEE, INDIVIOR | |||
2026-05-22 | NP |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Nalmefene Hydrochloride, Opvee, Indivior | |||
11458091 | 2038-07-10 | DP | U-3630 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alcoholism | D000437 | EFO_0003829 | F10.1 | 2 | — | 5 | 2 | — | 9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alcohol drinking | D000428 | EFO_0004329 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal insufficiency | D051437 | — | N19 | 1 | — | — | — | — | 1 |
Drug common name | Nalmefene |
INN | nalmefene |
Description | Nalmefene is a morphinane alkaloid. |
Classification | Small molecule |
Drug class | narcotic agonists/antagonists (normorphine type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5 |
PDB | — |
CAS-ID | 55096-26-9 |
RxCUI | — |
ChEMBL ID | CHEMBL982 |
ChEBI ID | 7457 |
PubChem CID | 5284594 |
DrugBank | DB06230 |
UNII ID | TOV02TDP9I (ChemIDplus, GSRS) |